Case Study: Leading Pharmaceutical Manufacturing Company achieves 100% downstream inventory visibility and improved channel performance with IntegriChain

Solving the Inventory Visibility and Channel Data Challenge

Leading Pharmaceutical Manufacturing Company, after launching a retail pharmacy migraine therapy and relying on 3PL partners, faced limited downstream inventory visibility, weak channel data, and difficulty benchmarking channel performance. The company had already engaged IntegriChain for Government Pricing and Rebate Managed Services and expanded that relationship to request Channel Advisory support for analysis, benchmarking, Bona Fide Service Fees (BFSF) and pre-deal analytics.

IntegriChain implemented channel data aggregation and inventory analytics (using sales and EDI 867 data), delivered high-decile pharmacy lists and market-basket comparisons, and unified channel data with its pricing and GTN services. As a result, the manufacturer gained 100% visibility to downstream inventory, improved channel performance, reduced stock-out and returns risk, and established a scalable platform for future launches and more accurate GTN accruals and forecasting.